Acebrophylline

• New generation airway mucus regulator
• Better reduction in the viscosity and adhesivity of the mucus greatly improves ciliary clearance
• No side effects induced by xanthine type antitussive
• Significant improvement in lung function as mucoreg facilitates biosynthesis of pulmonary
• Reduces the use of short acting Beta 2 against inhalers

Fexofenadine

• Effective in reducing the total symptom score of allergic rhinitis including blocked nose.
• Considered safe for pediatric patient as young as 6 years of age

Montelukast

• Potent leukotriene receptor antagonist
• Relieves the symptoms of indoor and outdoor allergies
• FDA approved for exercise induced broncho constriction.